Rival Drug Companies Team Up for COVID-19 Vaccines

Some of the world’s biggest drugmakers are joining forces with rivals to help produce Covid-19 vaccines, forging unusual alliances that promise to substantially increase supplies by this summer.

Normally big pharmaceutical companies compete to sell cancer, arthritis and other drugs. The desperate need for Covid-19 vaccines, however, is turning fierce industry competitors into fast pandemic friends.

Read more:

https://www.wsj.com/articles/to-make-more-covid-19-vaccines-rival-drugmakers-team-up-11614081601?mod=hp_lead_pos6

Novavax Nears COVID-19 Game Changer–After Years of Failure

We find your missing clients and obtain their signatures.

Today, Novavax is advancing toward authorization of a Covid-19 vaccine. Scientists believe that, if cleared, it could be one of the more powerful weapons against the pandemic, offering key possible advantages over its competitors. Some early data suggest the Novavax shot may be one of the first shown to stem asymptomatic spread of the coronavirus and also potentially provide longer-lasting protection.

Read more: https://www.wsj.com/articles/novavax-nears-covid-19-vaccine-game-changerafter-years-of-failure-11614096579?mod=hp_lead_pos5

J&J RESERVES $4B FOR TALC VERDICT, EXPENSES.

We find your missing clients and obtain their signatures.

Johnson & Johnson said in a securities filing Monday that it had set aside nearly $4 billion in 2020 to cover talc settlements and a $2.1 billion verdict in favor of women who claimed its talc products caused cancer, which the company is currently appealing to the U.S. Supreme Court.
J&J is currently seeking the high court’s review of the estimated $2.1 billion verdict. In June, the Missouri Court of Appeals trimmed a 2018 $4.7 billion verdict in favor of 22 women who claimed that J&J’s baby powder caused their ovarian cancer; the court later passed on taking another look at its ruling and the state high court also refused to review the ruling.
J&J now faces 25,000 cases over its talc products, and the number of personal injury cases over its baby powder products continues to grow.
Most of the cases are pending in multidistrict litigation in New Jersey federal court. Lawsuits have also been filed in New Jersey, Missouri and California state courts.

link: https://www.law360.com/productliability/articles/1358015/j-j-reserves-4b-for-talc-verdict-expenses